ArticleDiagnostics (Basel, Switzerland)2022

Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy.

Milos Holanek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.